LIFEOS GENOMICS CORPORATION
Update：2023/06/12
Industries
Main Industry
Biotechnology
Main Product/Service
1. LifeOS Developed Assay Panels
2. Assay Co-Development
3. QLoci? NIPT Assay Panel
4. Maximize your utility on the QLoci? system.
2. Assay Co-Development
3. QLoci? NIPT Assay Panel
4. Maximize your utility on the QLoci? system.
Founded Year
2015
Unified Business No.
24859657
Status
Active
Number of Employees
0
Total Paid-in
Capital
34,833,900 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
LifeOS Genomics is a biotechnology and in-vitro diagnostics company focused on IVD genetic testing using liquid biopsy. LifeOS Genomic’s flagship product, the QLoci System, is an automated genetic testing platform based on our novel multiplex digital PCR technology (mdPCR). By leveraging the unique high multiplexity and sensitivity of this PCR technology, LifeOS aims to decentralize and enable the routine practice genetic testing.
Founder Timothy Liu, Ph.D., assembled a team of experts in genetics, chemistry, automation, optics, and medical software to design and develop a medical device that focuses on the IVD experience. LifeOS is positioning the mdPCR platform as a testing solution for a myriad of genetic diseases, with promising applications in non-invasive prenatal testing, early cancer screening, companion diagnostics, infectious disease monitoring, and other areas requiring high multiplexity and high sensitivity.
Founder Timothy Liu, Ph.D., assembled a team of experts in genetics, chemistry, automation, optics, and medical software to design and develop a medical device that focuses on the IVD experience. LifeOS is positioning the mdPCR platform as a testing solution for a myriad of genetic diseases, with promising applications in non-invasive prenatal testing, early cancer screening, companion diagnostics, infectious disease monitoring, and other areas requiring high multiplexity and high sensitivity.
